Signature Resources Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Signature Resources Capital Management's VRTX Position: Q2 2026 in Review
Signature Resources Capital Management held its Vertex Pharmaceuticals (VRTX) position steady in Q2 2026 at 6 shares worth $2.98K. The position accounts for ﹤0.01% of the portfolio, ranked #496.
Signature Resources Capital Management first reported a position in VRTX in Q2 2025 and has held it in 5 quarters since. The position peaked at $10.9K in Q4 2025. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Signature Resources Capital Management held 6 shares of Vertex Pharmaceuticals worth $2.98K as of Q2 2026.
- Signature Resources Capital Management left its Vertex Pharmaceuticals share count unchanged in Q2 2026.
- Vertex Pharmaceuticals made up ﹤0.01% of Signature Resources Capital Management's portfolio in Q2 2026, its #496 holding.
- Signature Resources Capital Management first reported a position in Vertex Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
- Signature Resources Capital Management's Vertex Pharmaceuticals position peaked at $10.9K in Q4 2025.
- 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Signature Resources Capital Management's 13F filing for Q2 2026, filed 14 Jul 2026.